Mesenteric and mesocolic lymph node metastases from ovarian carcinoma: A clinicopathological analysis

被引:0
作者
Lax, SF
Petru, E
Holzer, E
Pertl, AM
Ralph, G
Greenspan, DL
Berger, A
Jatzko, G
机构
[1] Graz Univ, Dept Pathol, A-8036 Graz, Austria
[2] Graz Univ, Dept Obstet & Gynecol, A-8036 Graz, Austria
[3] Hosp Barmherzige Bruder, Dept Gynecol, Graz, Austria
[4] Hosp Barmherzige Bruder, Dept Surg, Graz, Austria
[5] Hosp Barmherzige Bruder, Dept Surg, St Veit Glan, Austria
[6] State Hosp, Dept Obstet & Gynecol, Bruck Mur, Austria
关键词
bowel; mesenteric/mesocolic lymph nodes; metastases; ovarian cancer; ovarian carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to analyze the clinicopathological features of ovarian carcinomas with metastases to mesenteric or mesocolic lymph nodes. Thirty patients with primary ovarian carcinomas metastatic to the bowel were analyzed for the extent of bowel infiltration, lymph node involvement, lymphatic channel involvement, and the number of examined lymph nodes. Metastases to mesenteric or mesocolic lymph nodes were found in 20 of the 30 patients. Metastases to mesenteric/mesocolic lymph nodes were more frequently associated with lymph vascular invasion at the site of the bowel implants and metastatic involvement of multiple bowel segments compared to mesenteric/mesocolic node-negative cases (P < 0.04). There was no significant difference between the mesenteric/mesocolic node-positive and node-negative patients with regard to FIGO stage, histologic type, tumor grade, residual tumor after surgery, gross pattern of bowel metastases, and involvement of retroperitoneal lymph nodes. While the presence of mesenteric/mesocolic lymph node metastases tended to be associated with shorter survival, this was not statistically significant. The prognostic and putative therapeutic importance of positive mesenteric/mesocolic lymph nodes in ovarian carcinoma awaits further evaluation in a larger number of cases.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 17 条
[1]  
AVERETTE HE, 1983, CANCER CAMPAIGN, V7, P101
[2]  
BOUWMAN DL, 1988, GASTROENTEROL CLIN N, V17, P859
[3]   SURGERY OF THE OVARIAN-CARCINOMA [J].
BURGHARDT, E ;
LAHOUSEN, M ;
STETTNER, H .
GEBURTSHILFE UND FRAUENHEILKUNDE, 1990, 50 (09) :670-677
[4]   THE SIGNIFICANCE OF PELVIC AND PARA-AORTIC LYMPHADENECTOMY IN THE OPERATIVE TREATMENT OF OVARIAN-CANCER [J].
BURGHARDT, E ;
LAHOUSEN, M ;
STETTNER, H .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1989, 3 (01) :157-165
[5]   INCIDENCE OF PARA-AORTIC AND PELVIC LYMPH-NODE METASTASES IN EPITHELIAL CARCINOMA OF THE OVARY [J].
CHEN, SS ;
LEE, L .
GYNECOLOGIC ONCOLOGY, 1983, 16 (01) :95-100
[6]   STAGE-III EPITHELIAL OVARIAN-CANCER - THE ROLE OF MAXIMAL SURGICAL REDUCTION [J].
DELGADO, G ;
ORAM, DH ;
PETRILLI, ES .
GYNECOLOGIC ONCOLOGY, 1984, 18 (03) :293-298
[7]   DISTRIBUTION OF DISEASE AT AUTOPSY IN 100 WOMEN WITH OVARIAN-CANCER [J].
DVORETSKY, PM ;
RICHARDS, KA ;
ANGEL, C ;
RABINOWITZ, L ;
STOLER, MH ;
BEECHAM, JB ;
BONFIGLIO, TA .
HUMAN PATHOLOGY, 1988, 19 (01) :57-63
[8]  
GANNON B, 1989, GASTROINTESTINAL OES, P117
[9]  
GELL G, 1983, METHOD INFORM MED, V22, P63
[10]  
HERMANEK P, 1988, WIEN MED WOCHENSCHR, V138, P292